PREDICTING PROSTATE CANCER SPECIFIC OUTCOME AFTER RADICAL PROSTATECTOMY AMONG MEN WITH CT3B/4 PCA WITH OR WITHOUT ADDITIONAL HIGH RISK FACTORS: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 266 PATIENTS

被引：0
|
作者：
Moltzahn, Felix
Karnes, Jeffrey A.
Gontero, Paolo
Kneitz, Burkhard
Tombal, Bertrand
Bader, Pia
Frohneberg, Detlef
van Poppel, Hein
Joniau, Steven
Spahn, Martin
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期
关键词：
D O I：
10.1016/j.juro.2014.02.1201
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP45-04
引用
收藏
页码：E460 / E460
页数：1
相关论文
共 39 条
  • [1] Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients
    F Moltzahn
    J Karnes
    P Gontero
    B Kneitz
    B Tombal
    P Bader
    A Briganti
    F Montorsi
    H Van Poppel
    S Joniau
    M Spahn
    [J]. Prostate Cancer and Prostatic Diseases, 2015, 18 : 31 - 37
  • [2] Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients
    Moltzahn, F.
    Karnes, J.
    Gontero, P.
    Kneitz, B.
    Tombal, B.
    Bader, P.
    Briganti, A.
    Montorsi, F.
    Van Poppel, H.
    Joniau, S.
    Spahn, M.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2015, 18 (01) : 31 - 37
  • [3] Re: Predicting Prostate Cancer-specific Outcome After Radical Prostatectomy Among Men with Very High-risk cT3b/4 PCa: A Multi-institutional Outcome Study of 266 Patients
    Kliment, Jan
    [J]. EUROPEAN UROLOGY, 2016, 70 (03) : 541 - 542
  • [4] PREDICTING PROSTATE CANCER SPECIFIC OUTCOME AFTER RADICAL PROSTATECTOMY AMONG MEN WITH PSA &[GE] 20 NG/ML WITH OR WITHOUT ADDITIONAL HIGH RISK FACTORS: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 712 PATIENTS
    Spahn, Martin
    Gontero, Paolo
    Kneitz, Burkhard
    Tombal, Bertrand
    Hsu, Belgium C-J
    Van der Eeckt, Kathie
    Marchioro, Giansilvio
    Bader, Pia
    Frohneberg, Detlef
    Van Poppel, Hein
    Joniau, Steven
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E227 - E227
  • [5] PREDICTING PROSTATE CANCER SPECIFIC OUTCOME AMONG MEN WITH PSA ≥ 20 NG/ML AND MULTIPLE UNFAVOURABLE RISK FACTORS: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 712 PATIENTS
    Spahn, M.
    Gontero, P.
    Kneitz, B.
    Tombal, B.
    Hsu, C. Y.
    Van Der, K.
    Marchiori, G.
    Bader, P.
    Frohneberg, D.
    Tizzani, A.
    Van Poppel, H.
    Joniau, S.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 267 - 267
  • [6] PREDICTING PROSTATE CANCER-SPECIFIC OUTCOME AMONG MEN WITH PSA ≥20 ng/ml AND MULTIPLE UNFAVOURABLE RISK FACTORS: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 712 PATIENTS
    Spahn, M.
    Gontero, P.
    Joniau, S.
    Marchioro, G.
    Fieuws, S.
    Tombal, B.
    Kneitz, B.
    Hsu, C. Y.
    Van Der Eeckt, K.
    Bader, P.
    Frohneberg, D.
    Frea, B.
    Terrone, C.
    Tizzani, A.
    Van Poppel, H.
    [J]. ANTICANCER RESEARCH, 2010, 30 (04) : 1439 - 1439
  • [7] Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients
    Spahn, Martin
    Morlacco, Alessandro
    Boxler, Silvan
    Joniau, Steven
    Briganti, Alberto
    Montorsi, Francesco
    Gontero, Paolo
    Bader, Pia
    Frohneberg, Detlef
    van Poppel, Hein
    Karnes, Robert Jeffrey
    [J]. BJU INTERNATIONAL, 2017, 120 (5B) : E52 - E58
  • [8] Outcome of multimodality treatment of cT4 very high-risk prostate cancer with radical cystectomy as initial step: A multi-institutional outcome study of 62 patients
    Spahn, M.
    Joniau, S.
    Abdollah, F.
    Tutolo, M.
    Di Trapani, E.
    Gontero, P.
    Kneitz, B.
    Bader, P.
    Frohneberg, D.
    Van Poppel, H.
    Karnes, R. J.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E362 - U819
  • [9] Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study
    Baykal, Kadir
    Soydan, Hasan
    [J]. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2007, 6 (02): : 33 - 35
  • [10] Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: A multi-institutional pilot study
    Kibel, Adam S.
    Rosenbaum, Eli
    Kattan, Michael W.
    Picus, Joel
    Dreicer, Robert
    Klein, Eric A.
    Chatta, Gurkamal S.
    Nelson, Joel B.
    DiPaola, Robert S.
    Roth, Bruce J.
    Cookson, Michael S.
    Wilding, George
    Jarrard, David F.
    Beer, Tomasz M.
    Ryan, Christopher W.
    Petrylak, Daniel P.
    Benson, Mitchell C.
    Partin, Alan W.
    Garrett-Mayer, Elizabeth
    Eisenberger, Mario A.
    [J]. JOURNAL OF UROLOGY, 2007, 177 (05): : 1777 - 1781
1234